Cita APA

Pérez-García, J. M., Gil-Gil, M. J., Ruiz Borrego, M., Comerma Blesa, L., Bellet Ezquerra, M., Curigliano, G., & Albanell, J. (2023). Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial.

Citación estilo Chicago

Pérez-García, José Manuel, Miguel J. Gil-Gil, Manuel Ruiz Borrego, Laura Comerma Blesa, Meritxell Bellet Ezquerra, Giuseppe Curigliano, y Joan Albanell. Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings From the Phase II BioPER Trial. 2023.

Cita MLA

Pérez-García, José Manuel, et al. Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings From the Phase II BioPER Trial. 2023.